GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 30 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | -66.7% | 1,900 | -51.3% | 0.00% | – |
| Q2 2019 | $3,000 | -62.5% | 3,900 | -43.5% | 0.00% | – |
| Q1 2019 | $8,000 | -20.0% | 6,900 | -42.0% | 0.00% | – |
| Q4 2018 | $10,000 | -64.3% | 11,900 | -13.8% | 0.00% | – |
| Q3 2018 | $28,000 | -91.3% | 13,800 | -56.5% | 0.00% | – |
| Q2 2018 | $323,000 | +122.8% | 31,700 | +42.8% | 0.00% | – |
| Q1 2018 | $145,000 | -5.2% | 22,200 | +15.6% | 0.00% | – |
| Q4 2017 | $153,000 | -15.0% | 19,200 | +1.6% | 0.00% | – |
| Q3 2017 | $180,000 | +30.4% | 18,900 | +75.9% | 0.00% | – |
| Q2 2017 | $138,000 | – | 10,743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|